Aptar Pharma to showcase an industry first

12 Sep 2018

PureHale is a new portable drug delivery device designed for upper respiratory care.

Aptar Pharma will showcase an industry first with its PureHale device – a new portable drug delivery device designed for upper respiratory care - at CPhI Worldwide this year in Madrid.

Aptar Pharma to showcase an industry first

In addition to PureHale, Aptar Pharma will also reveal:

  • A range of new connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes
  • A portfolio of gamma-sterilized drug delivery components to reduce bioburden
  • Aptar Pharma’s Support Services initiative, a portfolio of stage-specific development packages to help customers in their journey from molecule to market.
  • “Through a wide range of consulting and services, Aptar Pharma innovates around delivery routes, effective drug delivery, testing and regulatory requirements with partners ranging from small-scale R&D firms to the largest international pharmaceutical companies. We look forward to launching our Support Services initiative at CPhI, and working with our customers to meet their development needs, said Guillaume Brouet, Vice President Analytical, Regulatory and Scientific Affairs at Aptar Pharma.”

    Along with showcasing its range of innovative drug delivery devices that address nasal, pulmonary, eye care, injectables and dermal drug delivery routes at Aptar Pharma’s exhibit stand, the company will also be sharing various new solutions in prescription and over-the-counter treatments.

    Furthermore, Aptar Pharma executives will be delivering three Pharma Insight Briefings outlining the latest trends, technology and product innovations:

    “Debunking the leachable myths of gamma sterilization: A migration study of steam vs gamma”

    Julie D. Suman, President of Next Breath, a division of Aptar Pharma, Tuesday 9 October, 11:50-12:20.

    Julie Suman will present a migration study commissioned by Aptar Pharma to assess the impact of both steam sterilization and gamma sterilization on leachable profiles.

    “Portable care for your respiratory tract: Exploring new technology platforms”

    Guenter Nadler, Director Business Development, Aptar Pharma, Tuesday 9 October, 12:30-13:00

    Guenter Nadler will discuss new trends in treating upper respiratory tract issues naturally, including new respiratory technology platforms that will meet new market needs.

    “Building a connected devices eco-system for digital medicines”

    Sai Shankar, Director Business Development, Aptar Pharma Wednesday 10 October, 13:50-14:20.

    Sai Shankar will highlight the need for a digital medicine eco-system to ensure connected devices are fully optimised through patient-centric design, secure data collection and management, and cross-platform interoperability.

    Read More

    Related news

    Vetter's Skokie facility expansion nears completion

    Vetter's Skokie facility expansion nears completion

    17 Apr 2019

    Expansions will help meet an increase in customer projects; a second extension is in the final planning stage.

    Read more 
    Catalent to acquire gene therapy leader Paragon Bioservices

    Catalent to acquire gene therapy leader Paragon Bioservices

    16 Apr 2019

    Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare.

    Read more 
    Colorcon expands functional film coatings through the CR Alliance with DuPont

    Colorcon expands functional film coatings through the CR Alliance with DuPont

    15 Apr 2019

    The Aquacoat product line provides modified release drug profiles with the added benefit of global regulatory acceptance.

    Read more 
    Hovione Technology acquires global rights to new pulmonary inhaler device

    Hovione Technology acquires global rights to new pulmonary inhaler device

    15 Apr 2019

    The Papillon DPI is a single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments.

    Read more 
    Exploristics surges ahead with £1m investment

    Exploristics surges ahead with £1m investment

    15 Apr 2019

    The loan will be used to develop KERUS Cloud - currently the only software that can simulate trials with multiple correlated outcomes - by integrating it into an intelligent software ecosystem.

    Read more 
    Catalent celebrates opening of second Shanghai facility

    Catalent celebrates opening of second Shanghai facility

    14 Apr 2019

    Catalent’s two Shanghai locations will provide sponsors with an optimized supply solution for studies being undertaken in China, the Asia-Pacific region and globally.

    Read more 
    Global collaboration to innovate more natural and additive-free nutraceuticals

    Global collaboration to innovate more natural and additive-free nutraceuticals

    12 Apr 2019

    Initiative will enable Sirio Pharma to keep abreast of regional trends, new ingredients, dosage forms and claims to provide customers unique product ideas for line extensions.

    Read more 
    Isotype-specific secondary antibodies for improved signal detection

    Isotype-specific secondary antibodies for improved signal detection

    10 Apr 2019

    Offers an alternative to cross-adsorbed secondary antibodies when absolute specificity is required.

    Read more 
    Sterling Pharma to acquire CiVentiChem in the US

    Sterling Pharma to acquire CiVentiChem in the US

    9 Apr 2019

    The acquisition will enhance the CDMO's chemistry development capabilities to support pre-clinical and early phase clinical supply.

    Read more 
    New China-based biotechs fueling growth in manufacturing across China

    New China-based biotechs fueling growth in manufacturing across China

    9 Apr 2019

    New guidelines will see poorer quality manufacturers drop out of the market.

    Read more